Long-term safety profile of siplizumab, a humanized anti-CD2 monoclonal antibody, in subjects with chronic plaque psoriasis

doi:10.5580/1997

Long-term safety profile of siplizumab, a humanized anti-CD2 monoclonal antibody, in subjects with chronic plaque psoriasis

The Internet Journal of Dermatology ◽

10.5580/1997 ◽

2009 ◽

Vol 7 (2) ◽

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Safety Profile ◽

Chronic Plaque Psoriasis

Download Full-text

Safety and tolerability of tildrakizumab, an anti–interleukin-23p19 monoclonal antibody, in patients with chronic plaque psoriasis over two years of treatment: Results from long-term extensions of two phase III clinical studies (reSURFACE 1 and reSURFACE 2)

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.05.998 ◽

2018 ◽

Vol 79 (3) ◽

pp. AB251

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Clinical Studies ◽

Phase Iii ◽

Treatment Results ◽

Chronic Plaque Psoriasis ◽

Two Phase

Download Full-text

Safety profile of ixekizumab, an anti–IL-17 monoclonal antibody, in chronic plaque psoriasis patients after at least 1 year of open label treatment

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2014.01.763 ◽

2014 ◽

Vol 70 (5) ◽

pp. AB184

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Safety Profile ◽

Chronic Plaque Psoriasis ◽

Open Label

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718340215.793493941 ◽

2014 ◽

Author(s):

Kamran Ghoreschi ◽

Sebastian Volc

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis ◽

Double Blind ◽

Phase Iii Study

Download Full-text

Long-Term Safety and Efficacy of Risankizumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: Results from a Phase 2 Open-Label Extension Trial

Dermatology and Therapy ◽

10.1007/s13555-021-00490-3 ◽

2021 ◽

Author(s):

Kim A. Papp ◽

Saskia de Vente ◽

Jiewei Zeng ◽

Mary Flack ◽

Byron Padilla ◽

...

Keyword(s):

Plaque Psoriasis ◽

Phase 2 ◽

Chronic Plaque Psoriasis ◽

Open Label ◽

Safety And Efficacy ◽

Open Label Extension ◽

Extension Trial

Download Full-text

Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, phase-III study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2014.01.897 ◽

2014 ◽

Vol 71 (3) ◽

pp. 484-492 ◽

Cited By ~ 49

Author(s):

D.S. Krupashankar ◽

Sunil Dogra ◽

Mahendra Kura ◽

Abir Saraswat ◽

Leelavathy Budamakuntla ◽

...

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis ◽

Double Blind ◽

Phase Iii Study

Download Full-text

25482 Secukinumab efficacy and safety profile in pediatric patients with severe chronic plaque psoriasis up to 1 year

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2021.06.263 ◽

2021 ◽

Vol 85 (3) ◽

pp. AB59

Author(s):

Christine Bodemer ◽

Andrzej Kaszuba ◽

Külli Kingo ◽

Athanasios Tsianakas ◽

Akimichi Morita ◽

...

Keyword(s):

Plaque Psoriasis ◽

Safety Profile ◽

Pediatric Patients ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis

Download Full-text

Long-term treatment of chronic plaque psoriasis with biological drugs can control platelet activation: targeting the bridge between inflammation and atherothrombosis

Advances in Dermatology and Allergology ◽

10.5114/ada.2017.67077 ◽

2017 ◽

Vol 2 ◽

pp. 131-137 ◽

Cited By ~ 2

Author(s):

Bartłomiej Kwiek ◽

Joanna Narbutt ◽

Anna Sysa-Jędrzejowska ◽

Andrzej Langner ◽

Aleksandra Lesiak

Keyword(s):

Platelet Activation ◽

Plaque Psoriasis ◽

Term Treatment ◽

Chronic Plaque Psoriasis ◽

Biological Drugs ◽

Long Term Treatment

Download Full-text

Safety of long-term treatment with cyclosporin A in resistant chronic plaque psoriasis: a retrospective case series

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/j.1468-3083.2004.00877.x ◽

2004 ◽

Vol 18 (2) ◽

pp. 169-172 ◽

Cited By ~ 11

Author(s):

M Garcia-Bustinduy ◽

M Escoda ◽

FJ Guimera ◽

M Saez ◽

S Dorta ◽

...

Keyword(s):

Cyclosporin A ◽

Plaque Psoriasis ◽

Case Series ◽

Term Treatment ◽

Chronic Plaque Psoriasis ◽

Retrospective Case ◽

Retrospective Case Series ◽

Long Term Treatment

Download Full-text

Sustained long-term remission of chronic plaque psoriasis upon treatment with multiple courses of alefacept

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2007.10.029 ◽

2008 ◽

Vol 58 (2) ◽

pp. AB3

Keyword(s):

Plaque Psoriasis ◽

Chronic Plaque Psoriasis

Download Full-text

Long-term treatment of chronic plaque psoriasis with calcipotriol

Journal of Dermatological Treatment ◽

10.3109/09546639309089517 ◽

1993 ◽

Vol 4 (4) ◽

pp. 173-177 ◽

Cited By ~ 33

Author(s):

T Poyner ◽

Iw Hughes ◽

Bk Dass ◽

Pi Adnitt

Keyword(s):

Plaque Psoriasis ◽

Term Treatment ◽

Chronic Plaque Psoriasis ◽

Long Term Treatment

Download Full-text